Prednisolone Acetate Suspension/ Drops
Loading...Prednisolone Acetate Suspension/ Drops Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Prolonged use of corticosteroids may result in glaucoma with damage to the optic nerve, defects in visual acuity and fields of vision, and in posterior subcapsular cataract formation. Prolonged use may also suppress the host immune response and thus increase the hazard of secondary ocular infections.
Various ocular diseases and long-term use of topical corticosteroids have been known to cause corneal and scleral thinning. Use of topical corticosteroids in the presence of thin corneal or scleral tissue may lead to perforation.
Acute purulent infections of the eye may be masked or activity enhanced by the presence of corticosteroid medication.
If this product is used for 10 days or longer, intraocular pressure should be routinely monitored even though it may be difficult in children and uncooperative patients. Steroids should be used with caution in the presence of glaucoma. Intraocular pressure should be checked frequently.
The use of steroids after cataract surgery may delay healing and increase the incidence of bleb formation.
Use of ocular steroids may prolong the course and may exacerbate the severity of many viral infections of the eye (including herpes simplex). Employment of a corticosteroid medication in the treatment of patients with a history of herpes simplex requires great caution; frequent slit lamp microscopy is recommended.
Corticosteroids are not effective in mustard gas keratitis and Sjögren's keratoconjunctivitis.
Contains sodium bisulfite, a sulfite that may cause allergic-type reactions, including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Prednisolone acetate ophthalmic suspension 1.0% is indicated for the treatment of steroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe.
History
There is currently no drug history available for this drug.
Other Information
Prednisolone acetate ophthalmic suspension, USP 1.0% is a topical anti-inflammatory agent for ophthalmic use.
Chemical Name:
11ß,17, 21-Trihydroxypregna-1,4-diene-3, 20-dione 21-acetate
Contains: Active: prednisolone acetate (microfine suspension) 1.0%. Preservative: benzalkonium chloride. Inactives: boric acid; edetate disodium; hypromellose; polysorbate 80; purified water; sodium bisulfite; sodium chloride; and sodium citrate. The pH during its shelf life ranges from 5.0 - 6.0.
Structural Formula:
prednisolone acetate
Sources
Prednisolone Acetate Suspension/ Drops Manufacturers
-
H.j. Harkins Company, Inc.
![Prednisolone Acetate Suspension/ Drops [H.j. Harkins Company, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Prednisolone Acetate Suspension/ Drops | H.j. Harkins Company, Inc.
Shake well before using. Instill one to two drops into the conjunctival sac two to four times daily. During the initial 24 to 48 hours, the dosing frequency may be increased if necessary. Care should be taken not to discontinue therapy prematurely.
If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated (see PRECAUTIONS).
-
Preferred Pharmaceuticals, Inc.
Prednisolone Acetate Suspension/ Drops | Preferred Pharmaceuticals, Inc.
Shake well before using. Instill one to two drops into the conjunctival sac two to four times daily. During the initial 24 to 48 hours, the dosing frequency may be increased if necessary. Care should be taken not to discontinue therapy prematurely.
If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated (see PRECAUTIONS).
-
Remedyrepack Inc.
Prednisolone Acetate Suspension/ Drops | Remedyrepack Inc.
Shake well before using. Instill one to two drops into the conjunctival sac two to four times daily. During the initial 24 to 48 hours, the dosing frequency may be increased if necessary. Care should be taken not to discontinue therapy prematurely.
If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated (see PRECAUTIONS).
-
Pacific Pharma, Inc.
Prednisolone Acetate Suspension/ Drops | Pacific Pharma, Inc.
Shake well before using. Instill one to two drops into the conjunctival sac two to four times daily. During the initial 24 to 48 hours, the dosing frequency may be increased if necessary. Care should be taken not to discontinue therapy prematurely.
If signs and symptoms fail to improve after 2 days, the patient should be re-evaluated (see PRECAUTIONS).
![Prednisolone Acetate Suspension/ Drops [Preferred Pharmaceuticals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=4bf2d51d-2944-4450-a817-1baec6a909ef&name=4bf2d51d-2944-4450-a817-1baec6a909ef-03.jpg)
![Prednisolone Acetate Suspension/ Drops [Remedyrepack Inc. ]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b7d8267f-691f-4e18-b0dd-13b5c12ea016&name=MM3.jpg)
![Prednisolone Acetate Suspension/ Drops [Pacific Pharma, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1474d1df-70b6-4b1e-86d1-3349aa6d42fb&name=carton.jpg)
Login To Your Free Account